You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 3, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Romane Muletier1, Céline Bourgne2,3, Laurent Guy4
1Service d'Oncologie médicale, CHU Gabriel Montpied, Clermont-Ferrand, France.
DNA methylation is emerging as a key biomarker for prostate cancer classification and prognosis. Monitoring DNA methylation in circulating tumor DNA may predict treatment response, but further prospective studies are needed.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: